Filed: 8/11/2025ACC: 0001104659-25-076007
📋 What this filing means
KNOTT DAVID M JR filed this quarterly 13F‑HR report disclosing 85 equity positions with a total reported market value of $220.61M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
85
Positions
$220.61M
Total AUM (reported)
12.94M
Total Shares
Allocation by class
COMMON$220.61M100.0%
Portfolio Concentration
Top 3$108.66M49.3%
4–10$49.23M22.3%
11–25$37.54M17.0%
Rest$25.17M11.4%
Top 3 weight
49.3%
Top 10 weight
71.6%
Voting Authority Distribution
Total shares with voting rights: 12.94M
Sole
Full voting authority
12.94M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other85
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings85
Rows:
Calumet, Inc.
DFNDShares3.28M
TypeSH
Market value$51.60M
23.39%
Sole
3.28M
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$31.92M
14.47%
Sole
225K
Shared
0.00
None
0.00
Janus Henderson AAA CLO ETF
DFNDShares495.25K
TypeSH
Market value$25.13M
11.39%
Sole
495.25K
Shared
0.00
None
0.00
Alphabet Inc-Cl C
DFNDShares112.22K
TypeSH
Market value$19.91M
9.02%
Sole
112.22K
Shared
0.00
None
0.00
JPMorgan Chase & Co.
DFNDShares20.98K
TypeSH
Market value$6.08M
2.76%
Sole
20.98K
Shared
0.00
None
0.00
Verona Pharma PLC.
DFNDShares55K
TypeSH
Market value$5.20M
2.36%
Sole
55K
Shared
0.00
None
0.00
Xeris Biopharma Holdings, Inc.
DFNDShares1.06M
TypeSH
Market value$4.95M
2.24%
Sole
1.06M
Shared
0.00
None
0.00
DocGo, Inc.
DFNDShares3.07M
TypeSH
Market value$4.82M
2.19%
Sole
3.07M
Shared
0.00
None
0.00
Protagonist Therapeutics, Inc
DFNDShares80K
TypeSH
Market value$4.42M
2.00%
Sole
80K
Shared
0.00
None
0.00
Travere Therapeutics, Inc.
DFNDShares260K
TypeSH
Market value$3.85M
1.74%
Sole
260K
Shared
0.00
None
0.00
Catalyst Pharmaceuticals, Inc.
DFNDShares176K
TypeSH
Market value$3.82M
1.73%
Sole
176K
Shared
0.00
None
0.00
Avadel Pharmaceuticals plc
DFNDShares426K
TypeSH
Market value$3.77M
1.71%
Sole
426K
Shared
0.00
None
0.00
Bridgebio Pharma, Inc.
DFNDShares80K
TypeSH
Market value$3.45M
1.57%
Sole
80K
Shared
0.00
None
0.00
Syndax Pharmaceutical, Inc.
DFNDShares352.78K
TypeSH
Market value$3.30M
1.50%
Sole
352.78K
Shared
0.00
None
0.00
BioCryst Pharmaceuticals, Inc.
DFNDShares332.63K
TypeSH
Market value$2.98M
1.35%
Sole
332.63K
Shared
0.00
None
0.00
Inozyme Pharma, Inc.
DFNDShares666.20K
TypeSH
Market value$2.66M
1.21%
Sole
666.20K
Shared
0.00
None
0.00
Enstar Group Limited
DFNDShares7.50K
TypeSH
Market value$2.52M
1.14%
Sole
7.50K
Shared
0.00
None
0.00
LENZ Therapeutics, Inc.
DFNDShares82K
TypeSH
Market value$2.40M
1.09%
Sole
82K
Shared
0.00
None
0.00
CSX Corporation
DFNDShares70K
TypeSH
Market value$2.28M
1.04%
Sole
70K
Shared
0.00
None
0.00
AllianceBernstein Holding L.P.
DFNDShares48K
TypeSH
Market value$1.96M
0.89%
Sole
48K
Shared
0.00
None
0.00
Ultragenyx Pharmaceutical Inc.
DFNDShares52K
TypeSH
Market value$1.89M
0.86%
Sole
52K
Shared
0.00
None
0.00
Pfizer Inc.
DFNDShares74.54K
TypeSH
Market value$1.81M
0.82%
Sole
74.54K
Shared
0.00
None
0.00
Arcellx Inc
DFNDShares25.70K
TypeSH
Market value$1.69M
0.77%
Sole
25.70K
Shared
0.00
None
0.00
AtriCure, Inc.
DFNDShares46.44K
TypeSH
Market value$1.52M
0.69%
Sole
46.44K
Shared
0.00
None
0.00
Tectonic Therapeutic, Inc.
DFNDShares74K
TypeSH
Market value$1.47M
0.67%
Sole
74K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Calumet, Inc.DFND | Common | 3.28M | SH | $51.60M 23.39% | 3.28M | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $31.92M 14.47% | 225K | 0.00 | 0.00 |
Janus Henderson AAA CLO ETFDFND | Common | 495.25K | SH | $25.13M 11.39% | 495.25K | 0.00 | 0.00 |
Alphabet Inc-Cl CDFND | Common | 112.22K | SH | $19.91M 9.02% | 112.22K | 0.00 | 0.00 |
JPMorgan Chase & Co.DFND | Common | 20.98K | SH | $6.08M 2.76% | 20.98K | 0.00 | 0.00 |
Verona Pharma PLC.DFND | Common | 55K | SH | $5.20M 2.36% | 55K | 0.00 | 0.00 |
Xeris Biopharma Holdings, Inc.DFND | Common | 1.06M | SH | $4.95M 2.24% | 1.06M | 0.00 | 0.00 |
DocGo, Inc.DFND | Common | 3.07M | SH | $4.82M 2.19% | 3.07M | 0.00 | 0.00 |
Protagonist Therapeutics, IncDFND | Common | 80K | SH | $4.42M 2.00% | 80K | 0.00 | 0.00 |
Travere Therapeutics, Inc.DFND | Common | 260K | SH | $3.85M 1.74% | 260K | 0.00 | 0.00 |
Catalyst Pharmaceuticals, Inc.DFND | Common | 176K | SH | $3.82M 1.73% | 176K | 0.00 | 0.00 |
Avadel Pharmaceuticals plcDFND | Common | 426K | SH | $3.77M 1.71% | 426K | 0.00 | 0.00 |
Bridgebio Pharma, Inc.DFND | Common | 80K | SH | $3.45M 1.57% | 80K | 0.00 | 0.00 |
Syndax Pharmaceutical, Inc.DFND | Common | 352.78K | SH | $3.30M 1.50% | 352.78K | 0.00 | 0.00 |
BioCryst Pharmaceuticals, Inc.DFND | Common | 332.63K | SH | $2.98M 1.35% | 332.63K | 0.00 | 0.00 |
Inozyme Pharma, Inc.DFND | Common | 666.20K | SH | $2.66M 1.21% | 666.20K | 0.00 | 0.00 |
Enstar Group LimitedDFND | Common | 7.50K | SH | $2.52M 1.14% | 7.50K | 0.00 | 0.00 |
LENZ Therapeutics, Inc.DFND | Common | 82K | SH | $2.40M 1.09% | 82K | 0.00 | 0.00 |
CSX CorporationDFND | Common | 70K | SH | $2.28M 1.04% | 70K | 0.00 | 0.00 |
AllianceBernstein Holding L.P.DFND | Common | 48K | SH | $1.96M 0.89% | 48K | 0.00 | 0.00 |
Ultragenyx Pharmaceutical Inc.DFND | Common | 52K | SH | $1.89M 0.86% | 52K | 0.00 | 0.00 |
Pfizer Inc.DFND | Common | 74.54K | SH | $1.81M 0.82% | 74.54K | 0.00 | 0.00 |
Arcellx IncDFND | Common | 25.70K | SH | $1.69M 0.77% | 25.70K | 0.00 | 0.00 |
AtriCure, Inc.DFND | Common | 46.44K | SH | $1.52M 0.69% | 46.44K | 0.00 | 0.00 |
Tectonic Therapeutic, Inc.DFND | Common | 74K | SH | $1.47M 0.67% | 74K | 0.00 | 0.00 |
Page 1 of 4